SCHEMBL3198013

SCHEMBL3198013

O=C1C[C@H](c2ccco2)C([N+](=O)[O-])[C@@H](c2ccco2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.47
KMT2A Q03164 5/20 0.47
POLB P06746 4/20 0.47
TDP1 Q9NUW8 4/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 4/20 0.39
RECQL P46063 2/20 0.39
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
CHRM2 P08172 4/20 0.37
CHRM4 P08173 4/20 0.37
CHRM5 P08912 4/20 0.37
CHRM1 P11229 4/20 0.37
CHRM3 P20309 4/20 0.37
MEN1 O00255 3/20 0.36
GAA P10253 2/20 0.36
HTR1E P28566 1/20 0.36
ATM Q13315 1/20 0.36
S1PR3 Q99500 1/20 0.36
TLR9 Q9NR96 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3196883 1.00 MAPT (0.47) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL3204251 0.79 ALOX5 (0.36) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL3195782 0.71 MAPT (0.44) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL3202978 0.71 MAPT (0.44) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL15481317 0.65 ALOX5 (0.36) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL1177395 0.65 POLB (1.00) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL9141580 0.61
SCHEMBL28852941 0.61 MAPT (0.52) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL12464054 0.61 GAA (0.54) MAPTKMT2APOLBTDP1NPSR1
SCHEMBL4056038 0.61 GAA (0.54) MAPTKMT2APOLBTDP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859625-B2 Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses UNIVERSIDADE BANDEIRANTE DE SAO PAULO-ACADEMIA, PAULISTA ANCHIETA S/C LTDA (BR) 2014-10-14 US disclosed
US-20100029763-A1 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES UNIVERSIDADE BANDEIRANTE DE SAO PAULO-ACADEMIA, PAULISTA ANCHIETA S/C LTDA (BR) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029763-A1 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES CASP3, CYP8B1, DERA MAPT 4486/4885KMT2A 3228/4885POLB 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.